Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Vulvar Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Bone Mets

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Malignant Adenoma

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Brain Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Kaposi's Sarcoma

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Renal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

RESILIENT: A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) versus Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed on or after Platinum-based First-Line Therapy (MM-398-01-03-04)

  • Details

ClinicalTrials.gov ID: NCT03088813
Diagnosis Type: NA
USOR Number: 17099

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Pages